The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis
Open accessAbstract
The receptor activator of NF-kappaB (RANKL) is the essential signal required for full osteoclast (OC) development, activation, and survival. RANKL is highly expressed in areas of trabecular bone remodeling and inflammatory bone loss, is increased on marrow stromal cells or osteoblasts by osteotropic hormones or cytokines, and is neutralized by osteoprotegerin (OPG), a soluble decoy receptor also crucial for preventing arterial calcification. Vascular endothelial cells (VEC) are critically involved in bone development and remodeling and influence OC recruitment, formation, and activity. Although OCs develop and function in close association with bone VEC and sinusoids, signals mediating their interactions are not well known. Here, we show for the first time that human microvascular endothelial cells (HMVEC) express transcripts for both RANKL and OPG; inflammatory cytokines tumor necrosis factor-alpha and interleukin-1alpha elevate RANKL and OPG expression 5-40-fold in HMVEC (with an early OPG peak that declines as RANKL rises), and RANKL protein increases on the surface of tumor necrosis factor-alpha-activated HMVEC. Cytokine-activated HMVEC promoted the formation, fusion, and bone resorption of OCs formed in co-cultures with circulating human monocytic precursors via a RANKL-mediated mechanism fully antagonized by exogenous OPG. Furthermore, paraffin sections of human osteoporotic fractured bone exhibited increased RANKL immunostaining in vivo on VEC located near resorbing OCs in regions undergoing active bone turnover. Therefore, cytokine-activated VEC may contribute to inflammatory-mediated bone loss via regulated production of RANKL and OPG. VEC-derived OPG may also serve as an autocrine signal to inhibit blood vessel calcification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Osteoclastogenesis starts in the bone marrow upon the release of RANKL and macrophage colony-stimulating factor (M-CSF) from osteocytes and vascular endothelial cells close to the bone surface.138”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,246
Gerber, H. P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., & Ferrara, N. (1999) · Nature Medicine · doi:10.1038/9467 · Cited by 2,107
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Research works printed but not linked: 2
- Cines, 1998, Blood, 91, 3527
- Crutchley, 1985, J. Pharmacol. Exp. Ther., 233, 650
Cited by
Sorted by citations
Items 101–200 of 398
Stein, N., Kreutzmann, C., Zimmermann, S.-P., Niebergall, U., Hellmeyer, L., Goettsch, C., Schoppet, M., & Hofbauer, L. C. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080203 · Cited by 81
Osteoprotegerin in Cardiometabolic Disorders
de Ciriza, C. P., Lawrie, A., & Varo, N. (2015) · International Journal of Endocrinology · doi:10.1155/2015/564934 · Cited by 78
Campagnuolo, G., Bolon, B., & Feige, U. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10369 · Cited by 78
Cholesterol in Vascular and Valvular Calcification
Demer, L. L. (2001) · Circulation · doi:10.1161/circ.104.16.1881 · Cited by 79
Sims, N. A., & Quinn, J. M. W. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.22 · Cited by 78
Gannagé‐Yared, M., Fares, F., Semaan, M., Khalife, S., & Jambart, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02522.x · Cited by 76
Mollentze, J., Durandt, C., & Pepper, M. S. (2021) · Stem Cells International · doi:10.1155/2021/9919361 · Cited by 81
Relationship between serum RANKL and RANKL in bone
Findlay, D. M., & Atkins, G. J. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1740-9 · Cited by 76
Miyashita, T., Kawakami, A., Nakashima, T., Yamasaki, S., Tamai, M., Tanaka, F., Kamachi, M., Ida, H., Migita, K., Origuchi, T., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02534.x · Cited by 74
Demer, L. L., & Tintut, Y. (2011) · Circulation Research · doi:10.1161/circresaha.110.234245 · Cited by 76
Role of full-length osteoprotegerin in tumor cell biology
Zauli, G., Melloni, E., Capitani, S., & Secchiero, P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8536-x · Cited by 72
Linking angiogenesis to bone destruction in arthritis
Pap, T., & Distler, O. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21015 · Cited by 71
Bone Vascularization in Normal and Disease Conditions
Carulli, C., Innocenti, M., & Brandi, M. L. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00106 · Cited by 70
Duhéron, V., Hess, E., Duval, M., Décossas, M., Castañeda, B., Klöpper, J. E., Amoasii, L., Barbaroux, J.-B., Williams, I. R., Yagita∥, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013054108 · Cited by 71
Odgren, P. R., Kim, N., MacKay, C. A., Mason‐Savas, A., Choi, Y., & Marks, S. C. (2003) · Connective Tissue Research · doi:10.1080/03008200390181753 · Cited by 68
Skoumal, M., Kolarz, G., Haberhauer, G., Woloszczuk, W., Hawa, G., & Klingler, A. (2005) · Rheumatology International · doi:10.1007/s00296-004-0579-1 · Cited by 66
Stromal cell-derived factor-1 (CXCL12) and its role in bone and muscle biology
Gilbert, W. B., Bragg, R., Elmansi, A. M., McGee‐Lawrence, M. E., Isales, C. M., Hamrick, M. W., Hill, W., & Fulzele, S. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154783 · Cited by 67
A review of denosumab for the treatment of osteoporosis
Miyazaki, T., Tokimura, F., & Tanaka, S. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s46192 · Cited by 66
Haynes, D. R. (2004) · Inflammation Research · doi:10.1007/s00011-004-1303-z · Cited by 66
The osteo-angiogenic signaling crosstalk for bone regeneration: harmony out of complexity
Maggio, N. D., & Banfi, A. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102750 · Cited by 66
Ashley, D. T., O'Sullivan, E. P., Davenport, C., Devlin, N. F. C., Crowley, R. K., McCaffrey, N., Moyna, N. M., Smith, D., & O’Gorman, D. J. (2010) · Metabolism · doi:10.1016/j.metabol.2010.10.001 · Cited by 65
Effects of plyometric exercise session on markers of bone turnover in boys and young men
Kish, K., Mezil, Y., Ward, W. E., Klentrou, P., & Falk, B. (2015) · European Journal of Applied Physiology · doi:10.1007/s00421-015-3191-z · Cited by 65
MAPK Usage in Periodontal Disease Progression
Li, Q., Valerio, M. S., & Kirkwood, K. L. (2012) · Journal of Signal Transduction · doi:10.1155/2012/308943 · Cited by 63
Urine Osteoprotegerin and Monocyte Chemoattractant Protein-1 in Lupus Nephritis
Kiani, A. N., Johnson, K., Chen, C., Diehl, E. E., Hu, H., VASUDEVAN, G., Singh, S., Magder, L. S., Knechtle, S. J., & Petri, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081112 · Cited by 62
Barber, B. E., Grigg, M. J., Piera, K. A., William, T., Cooper, D. J., Plewes, K., Dondorp, A. M., Yeo, T. W., & Anstey, N. M. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0105-2 · Cited by 62
Yoshinaga, Y., Ukai, T., Abe, Y., & Hara, Y. (2007) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2007.00960.x · Cited by 62
Serum Osteoprotegerin Is Increased in Crohnʼs Disease: a Population-Based Case Control Study
Bernstein, C. N., Sargent, M. J., & Leslie, W. D. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000164015.60795.ca · Cited by 62
Oh, E. S., Rhee, E.-J., Oh, K. W., Lee, W. Y., Baek, K. H., Yoon, K. H., Kang, M. I., Yun, E. J., Park, C. Y., Choi, M. G., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.005 · Cited by 61
Breuil, V., Schmid‐Antomarchi, H., Schmid‐Alliana, A., Rezzonico, R., Euller‐Ziegler, L., & Rossi, B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1188fje · Cited by 62
TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
Bartolo, B. A. D., Cartland, S. P., Harith, H. H., Bobryshev, Y. V., Schoppet, M., & Kavurma, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074211 · Cited by 59
Dutka, M., Bobiński, R., Wojakowski, W., Francuz, T., Pająk, C., & Zimmer, K. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10153-2 · Cited by 58
Sakai, N., Sweringen, H. L. V., Schuster, R. M., Blanchard, J. A., Burns, J. M., Tevar, A. D., Edwards, M. J., & Lentsch, A. B. (2011) · Hepatology · doi:10.1002/hep.24756 · Cited by 58
Yaturu, S., Rains, J., & Jain, S. K. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.471 · Cited by 57
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Campagnuolo, G., Morony, S., Boyle, W. J., Zack, D. J., & Feige, U. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10680 · Cited by 57
RANKL Induces Organized Lymph Node Growth by Stromal Cell Proliferation
Hess, E., Duhéron, V., Décossas, M., Lézot, F., Berdal, A., Chea, S., Golub, R., Bosisio, M. R., Bridal, S. L., Choi, Y., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101513 · Cited by 56
Expression and Regulation of Osteoprotegerin in Adipose Tissue
An, J.-J., Han, D.-H., Kim, D.-M., Kim, S.-H., Rhee, Y., Lee, E. J., & Lim, S.-K. (2007) · Yonsei Medical Journal · doi:10.3349/ymj.2007.48.5.765 · Cited by 56
Mechanisms of bone loss in rheumatoid arthritis
Findlay, D. M., & Haynes, D. R. (2005) · Modern Rheumatology · doi:10.1007/s10165-005-0412-z · Cited by 56
Chim, S. M., Kuek, V., Chow, S. T., Lim, B. S., Tickner, J. C., Zhao, J., Chung, R., Su, Y., Zhang, G., Erber, W. N., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24684 · Cited by 53
Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis
Aoki, S., Honma, M., Kariya, Y., Nakamichi, Y., Ninomiya, T., Takahashi, N., Udagawa, N., & Suzuki, H. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.89 · Cited by 54
Commitment to the Osteoblast Lineage Is Not Required for RANKL Gene Expression
Galli, C., Fu, Q., Wang, W., Olsen, B. R., Manolagas, S. C., Jilka, R. L., & O’Brien, C. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806628200 · Cited by 51
Novel mechanisms in accelerated vascular calcification in renal disease patients
Demer, L. L., Tintut, Y., & Parhami, F. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200207000-00011 · Cited by 51
Søe, K., Delaisse, J.-M., & Borggaard, X. G. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.05.016 · Cited by 49
Vik, A., Mathiesen, E. B., Brox, J. H., Wilsgaard, T., Njølstad, I., Jørgensen, L., & Hansen, J. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03990.x · Cited by 50
Dextran sodium sulfate-induced colitis causes rapid bone loss in mice
Hamdani, G., Gabet, Y., Rachmilewitz, D., Karmeli, F., Bab, I., & Dresner–Pollak, R. (2008) · Bone · doi:10.1016/j.bone.2008.06.018 · Cited by 50
A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway
Raju, R., Balakrishnan, L., Nanjappa, V., Bhattacharjee, M., Getnet, D., Muthusamy, B., Thomas, J. K., Sharma, J. N., Rahiman, B. A., Gowda, H., et al. (2011) · Database · doi:10.1093/database/bar021 · Cited by 49
TRAIL and osteoprotegerin: a role in endothelial physiopathology?
Corallini, F. (2007) · Frontiers in bioscience · doi:10.2741/2665 · Cited by 50
Pepene, C. E., Ilie, I. R. P., Marian, I., & Duncea, I. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0720 · Cited by 49
de Vries, T. J., Schoenmaker, T., Aerts, D., Grevers, L. C., de Souza, P. C., Nazmi, K., van de Wiel, M. A., Ylstra, B., van Lent, P. L., Leenen, P. J. M., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24702 · Cited by 49
Chen, C., Chen, N.-C., Liang, H., Hsu, C., Chou, K.-J., Fang, H.-C., & Lee, P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1259 · Cited by 47
The role of stromal cells in inflammatory bone loss
Wehmeyer, C., Pap, T., Buckley, C. D., & Naylor, A. J. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12979 · Cited by 48
Nakamura, H., 由紀子, 福., Yoshimura, A., Shiraishi, C., Kishimoto, M., Kaneko, T., & Hara, Y. (2008) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2007.00410.x · Cited by 50
Reid, P. E., Brown, N. J., & Holen, I. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-49 · Cited by 46
Role of αv integrin in osteoprotegerin-induced endothelial cell migration and proliferation
Kobayashi‐Sakamoto, M., Isogai, E., Hirose, K., & Chiba, I. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.06.004 · Cited by 45
NF-κB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells
Kobayashi‐Sakamoto, M., Hirose, K., Isogai, E., & Chiba, I. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.024 · Cited by 45
Ugur‐Altun, B., Altun, A., Gerenli, M., & Tuğrul, A. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.10.011 · Cited by 44
Correlation between frontal sinus dimensions and cephalometric indices: A cross-sectional study
Tehranchi, A., Motamedian, S. R., Saedi, S., Kabiri, S., & Shidfar, S. (2017) · European Journal of Dentistry · doi:10.4103/1305-7456.202630 · Cited by 43
RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
Ritchlin, C. T., Schwarz, E. M., O’Keefe, R. J., & Looney, R. J. (2004) · PubMed · Cited by 43
RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice
Pin, F., Jones, A. J., Huot, J. R., Narasimhan, A., Zimmers, T. A., Bonewald, L. F., & Bonetto, A. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4480 · Cited by 42
Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men
Srikanth, P., Chun, R. F., Hewison, M., Adams, J. S., Bouillon, R., Vanderschueren, D., Lane, N. E., Cawthon, P. M., Dam, T.-T. L., Barrett-Connor, E. L., et al. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3537-3 · Cited by 41
Park, J. S., Cho, M. H., Nam, J. S., Yoo, J. S., Ahn, C. W., Soo, B., Kim, K. R., & Lee, H. C. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0875 · Cited by 44
Role of Osteoprotegerin and Its Ligands and Competing Receptors in Atherosclerotic Calcification
Tintut, Y., & Demer, L. L. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2006.06019 · Cited by 42
Saha, H., Mukherjee, B., Bindhani, B., & Ray, M. R. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3275 · Cited by 42
Cohen, E. B.-T., Hohensinner, P. J., Kaun, C., Maurer, G., Huber, K., & Wojta, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.007 · Cited by 41
Zhang, J., Lü, Y., Dai, J., Yao, Z., Kitazawa, R., Kitazawa, S., Zhao, X., Hall, D. E., Pienta, K. J., & Keller, E. T. (2003) · The Prostate · doi:10.1002/pros.20019 · Cited by 41
Soy phytoestrogens: impact on postmenopausal bone loss and mechanisms of action
Poulsen, R. C., & Kruger, M. C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00046.x · Cited by 41
El‐Asrar, A. M. A., Struyf, S., Mohammad, G., Gouwy, M., Rytinx, P., Siddiquei, M. M., Hernández, C., Alam, K., Mousa, A., Hertogh, G. D., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20993 · Cited by 40
Ishiyama, M., Suzuki, E., Katsuda, J., Murase, H., Tajima, Y., Horikawa, Y., Goto, S., Fujita, T., & Takeda, J. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.023 · Cited by 39
Microvascular Response in the Periodontal Ligament Following Mucoperiosteal Flap Surgery
Nobuto, T., Imai, H., Suwa, F., Kono, T., Suga, H., Jyoshi, K., & Obayashi, K. (2003) · Journal of Periodontology · doi:10.1902/jop.2003.74.4.521 · Cited by 39
Kirkwood, K. L., Martin, T. J., Andreadis, S. T., & Kim, Y. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00450-7 · Cited by 38
Osteoprotegerin as a marker of atherosclerosis: A systematic update
Hosbond, S. E., Poulsen, T. S., Diederichsen, A. C. P., Nybo, M., Rasmussen, L. M., & Mickley, H. (2012) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2012.685491 · Cited by 37
Rachner, T. D., Benad, P., Rauner, M., Goettsch, C., Singh, S. K., Schoppet, M., & Hofbauer, L. C. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22232 · Cited by 37
Morena-Carrere, M., Jaussent, I., Halkovich, A., Dupuy, A., Bargnoux, A., Chénine, L., Leray‐Moragues, H., Klouche, K., Vernhet, H., Canaud, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036175 · Cited by 38
RANKL inhibition for the management of patients with benign metabolic bone disorders
Anastasilakis, A. D., Toulis, K. A., Pοlyzos, S. A., & Terpos, E. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903048929 · Cited by 37
Kuek, V., Yang, Z., Chim, S. M., Zhu, S., Xu, H., Chow, S. T., Tickner, J. C., Rosen, V., Erber, W. N., Li, X., et al. (2016) · Scientific Reports · doi:10.1038/srep36210 · Cited by 37
Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells
Okada, T., Akikusa, S., Okuno, H., & Kodaka, M. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1027362507683 · Cited by 37
Kariya, Y., Honma, M., Hanamura, A., Aoki, S., Ninomiya, T., Nakamichi, Y., Udagawa, N., & Suzuki, H. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.268 · Cited by 36
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets
Toffoli, B., Bernardi, S., Candido, R., Sabato, N., Carretta, R., Corallini, F., Secchiero, P., Zauli, G., & Fabris, B. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.019 · Cited by 35
Antisense oligonucleotide targeting TNF‐α can suppress co‐cr‐mo particle‐induced osteolysis
Dong, L., Wang, R., Zhu, Y., Wang, C., Diao, H., Zhang, C., Zhao, J., & Zhang, J. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20607 · Cited by 35
Cenni, E., Ciapetti, G., Granchi, D., Fotia, C., Perut, F., Giunti, A., & Baldini, N. (2009) · Journal of Orthopaedic Research® · doi:10.1002/jor.20896 · Cited by 35
Bock, O., Loch, G., Schade, U. M., Büsche, G., von Wasielewski, R., Wiese, B., & Kreipe, H. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05573.x · Cited by 35
Wang, F.-S., Wang, C.-J., Chen, Y.-J., Huang, Y.-T., Huang, H.-C., Chang, P.-R., Sun, Y.-C., & Yang, K. D. (2004) · Endocrinology · doi:10.1210/en.2003-1074 · Cited by 35
In vitro models for the evaluation of angiogenic potential in bone engineering
Cenni, E., Perut, F., & Baldini, N. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.143 · Cited by 34
Skeleton and Glucose Metabolism: A Bone-Pancreas Loop
Faienza, M. F., Luce, V., Ventura, A., Colaianni, G., Colucci, S. C., Cavallo, L., Grano, M., & Brunetti, G. (2015) · International Journal of Endocrinology · doi:10.1155/2015/758148 · Cited by 35
Regulation of RANKL-induced osteoclastic differentiation by vascular cells
Tintut, Y., Abedin, M. Z., CHO, J., Choe, A., Lim, J. H., & Demer, L. L. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.03.019 · Cited by 34
Effendy, N. M., Shuid, A. N., Norazlina, M., Isa, N. M., Norliza, M., & Nirwana, S. I. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/706905 · Cited by 34
Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques
Bitto, A., Caridi, G. D., Polito, F., Calò, M., Irrera, N., Altavilla, D., Spinelli, F., & Squadrito, F. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.05.116 · Cited by 34
Andersen, G. Ø., Knudsen, E. C., Aukrust, P., Yndestad, A., Øie, E., Müller, C., Seljeflot, I., & Ueland, T. (2011) · Heart · doi:10.1136/hrt.2010.206714 · Cited by 33
Gürkan, A., Emingil, G., Nizam, N., Doğanavşargıl, B., Sezak, M., Kütükçüler, N., & Atilla, G. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.090031 · Cited by 33
Poulsen, R. C., Wolber, F. M., Moughan, P. J., & Kruger, M. C. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.10.004 · Cited by 34
Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males
Findlay, D. M., Chehade, M. J., Tsangari, H., Neale, S. D., Hay, S. J., Hopwood, B., Pannach, S., O’Loughlin, P. D., & Fazzalari, N. L. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2348 · Cited by 33
Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis
Walker, J. G., Stirling, J. W., Beroukas, D., Dharmapatni, K., Haynes, D. R., Smith, M., Ahern, M. J., & Roberts-Thomson, P. J. (2005) · Pathology · doi:10.1080/00313020500033262 · Cited by 32
Lee, J., Hong, S., Kim, M.-J., Kwon, H., Park, S. E., Rhee, E., & Lee, W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.136 · Cited by 31
Osteoprotegerin is expressed in colon carcinoma cells.
Pettersen, I., Bakkelund, W. H., Smedsrød, B. H., & Sveinbjørnsson, B. (2005) · PubMed · Cited by 31
Darowish, M., Rahman, R. K., Li, P., Bukata, S., Gelinas, J., Huang, W., Flick, L. M., Schwarz, E., & O'Keefe, R. (2009) · Bone · doi:10.1016/j.bone.2009.06.004 · Cited by 31
Zheng, T., Yang, L., Liu, Y., Liu, H., Yu, J. M., Zhang, X., & Qin, S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2233 · Cited by 30
Insights into the mechanism of vascular endothelial cells on bone biology
Yin, Y., Tang, Q., Xie, M., Li, H., & Chen, L. (2021) · Bioscience Reports · doi:10.1042/bsr20203258 · Cited by 29
Fortner, R. T., Sarink, D., Schöck, H., Johnson, T., Tjønneland, A. M., Olsen, A., Overvad, K., Affret, A., His, M., Boutron‐Ruault, M., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0786-8 · Cited by 30
Monocyte Proteomics Reveals Involvement of Phosphorylated HSP27 in the Pathogenesis of Osteoporosis
Daswani, B., Gupta, M. K., Gavali, S., Desai, M. P., Sathe, G. J., Patil, A. D., Parte, P. P., Sirdeshmukh, R., & Khatkhatay, M. I. (2015) · Disease Markers · doi:10.1155/2015/196589 · Cited by 29
Hassan, S., Elrefai, M., Ghallab, N. A., Kasem, R. F., & Shaker, O. G. (2015) · Disease Markers · doi:10.1155/2015/341259 · Cited by 28
TNFα Increases RANKL Expression via PGE2-Induced Activation of NFATc1
Park, H.-J., Baek, K., Baek, J., & Kim, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030495 · Cited by 32
Metadata
- Authors
- Collin-Osdoby, P., Rothe, L., Anderson, F., Nelson, M., Maloney, W., & Osdoby, P.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Osdoby, Philip
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 276
- Issue
- 23
- Pages
- 20659-20672
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2060482009
- Cited by
- 398
- References
- 57
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 12 · 2020: 10 · 2019: 5 · 2018: 10 · 2017: 13 · 2016: 10 · 2015: 24 · 2014: 15 · 2013: 12 · 2012: 25
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ar032927-12, AR32927)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK46547)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR32927)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- RANKL, osteoprotegerin, microvascular endothelial cells, osteoclastogenesis, TNF-α, interleukin-1 alpha, inflammatory cytokines, bone remodeling, bone resorption, osteoporosis, vascular calcification, RANK signaling
- MeSH terms
- Base Sequence, Bone Resorption, Cells, Cultured, Endothelium, Vascular, Gene Expression Regulation, Glycoproteins, Humans, Interleukin-1, Osteoclasts, RNA, Messenger, Tumor Necrosis Factor-alpha, Cytokines, DNA Primers, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Coculture Techniques, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
